Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-20 7:03 pm Purchase | 2026-02-19 | 13G | CDT EQUITY INC PAR $0.0001 CDT | Nirland Limited | 75,315 1.600% | 75,315 (New Position) | Filing History |
| 2025-02-20 4:32 pm Sale | 2025-02-19 | 13G | CONDUIT PHARMACEUTICALS INC CO CDT | Nirland Limited | 0 0.000% | -51 (Position Closed) | Filing History |
| 2025-01-21 5:00 pm Purchase | 2025-01-13 | 13G | CONDUIT PHARMACEUTICALS INC CO CDT | Nirland Limited | 51 9.979% | 44 (+628.57%) | Filing History |
| 2024-10-18 4:15 pm Sale | 2024-10-11 | 13G | CONDUIT PHARMACEUTICALS INC CO CDT | Nirland Limited | 7 2.000% | -20 (-74.07%) | Filing History |
| 2024-10-07 7:36 pm Sale | 2024-10-04 | 13G | CONDUIT PHARMACEUTICALS INC CO CDT | Nirland Limited | 27 8.300% | -21 (-43.75%) | Filing History |
| 2024-08-13 4:29 pm Purchase | 2024-08-06 | 13G | CONDUIT PHARMACEUTICALS INC CO CDT | Nirland Limited | 48 14.800% | 26 (+118.18%) | Filing History |
| 2023-10-02 4:30 pm Purchase | 2023-09-22 | 13G | CONDUIT PHARMACEUTICALS INC CO CDT | Nirland Limited | 22 8.800% | 22 (New Position) | Filing History |